Patent Application
20220227639
The present invention relates to a method for preparing nanoparticles having controlled structural and magnetic properties for biomedical applications, in particular for the application thereof as thermal mediators in magnetic hyperthermia.
Magnetic hyperthermia is a promising approach for the treatment of neoplastic diseases, which is able to bring about the selective killing of the tumor cells on account of the heat, without damaging the healthy cells at the same time. This treatment is based on the use of magnetic nanoparticles to bring about a localized increase in temperature in the target cancerous region by means of an increase in temperature of 42-45° C. The factors that determine the efficacy of this treatment are the alternating magnetic field (frequency and intensity) and the structural and colloidal properties of the nanoparticles used. The conditions of the alternating magnetic field are dictated by clinical conditions (in general, a frequency of 110 kHz and an intensity of between 10 and 24 kAm−1 are used on patients). In particular, it is known that cubic magnetite (Fe3O4) and maghemite (γ-Fe2O3) nanocrystals show, owing to their anisotropic characteristics, exceptional behavior compared with the corresponding spherical nanoparticles during magnetic hyperthermia. The typical dose of spherical nanoparticles required for magnetic hyperthermia treatment of a patient is 7-12 mL of a solution containing 100-120 mg Fe/mL, while the cubic nanocrystals, which have specific absorption rate values (commonly called SAR) that are twenty times greater than those of the spherical nanoparticles, would make it possible to considerably reduce the dose to be administered to each patient during the treatment.
The best properties, in terms of SAR, of the cubic nanocrystals originate closely from the controlling of the shape, dimensions and polydispersion obtainable during their preparation. Thus far, the best qualitative results during the preparation of cubic nanocrystals were obtained by means of methods for the thermal decomposition of organometallic precursors in the presence of surfactants, as mentioned in patent application WO 2013/150496, Guardia et al. A PROCESS FOR PREPARING FERRITE NANOCRYSTALS by the same applicant, possibly also in the presence of structure directing agents, as described in the scientific publication “One pot synthesis of monodisperse water soluble iron oxide nanocrystals with high values of the specific absorption rate,” by Guardia et al., J. Mater. Chem. B, 2014, 2,4426. Despite having optimum control of the magnetic and structural properties of the nanocubes, these methods make it possible to prepare a very small amount of material (a few tens of milligrams of iron nanocubes).
Solvothermal methods for preparing nanoparticles for magnetic hyperthermia have recently been proposed in the literature. In particular, Raja Das et al. in “Tunable High Aspect Ratio Iron Oxide Nanorods for Enhanced Hyerthermia,” published in J. Phys. Chem. C 2016 120, 10086-10093, report the synthesis of nanorods of Fe3O4 from an organometallic precursor, a surfactant and an organic base in the presence of 1-octanol as the solvent, after 6 hours at 200° C. in an autoclave. In a preliminary study mentioned in “Solvothermal Synthesis of Tunable Electroactive Magnetite Nanorods by Controlling the Side Reaction,” J. Phys. Chem. C 2012 116, 5476-5481, Sun et al. observed the formation of FeO (wüstite) nanocubes after a reaction period of 80 minutes, due to the decomposition and successive oxidation of Fe(CO)5 used as a precursor. The formation of FeO was, however, considered to be an intermediate process that develops in the magnetite phase as a result of thermal treatment (annealing) with exposure to a temperature of at least 200° C. for longer periods of time (from 6 to 24 hours), as confirmed by the absence thereof at the end of the synthesis process. A revision study conducted by Rafienia et al., “Solvothermal Synthesis of Magnetic Spinel Ferrites,” published in J. Med. Sign. Sens. 2018;8: 108-18, identified a few critical parameters for the solvothermal methods, such as the operating temperature (in the range of 100° C.-240° C.) and the need for long reaction times to obtain products having regular shapes. In particular, the authors cite a preparation of magnetite nanocubes having a narrow dimensional distribution and obtained in hydroalcoholic solvent after a reaction period of 24 hours at 230° C. and in the presence of polyethylene glycol (PEG) and sodium dodecyl sulfate (SDS) as directing agents.
However, none of the methods cited above makes it possible to obtain a good yield of magnetic nanoparticles having a high specific absorption rate and in a manner that may be implemented on a large scale. In the field of magnetic hyperthermia, there is therefore still a strong need to provide methods for preparing magnetic nanoparticles having optimum magnetic and colloidal properties for clinical application, which methods are easy to implement on a large scale.
The object of the present invention is to provide a synthesis method that overcomes the problems cited above.
In view of this object, the subject-matter of the invention consists of a method for preparing magnetic nanoparticles, which has the features defined in the following claims.
Additional advantages and the features of the method of the invention will become clear from the following description regarding both the general method features and specific embodiments.
In the attached drawings:
For the purposes of the present description, the following terms are understood as having the following meanings.
“Directing agent” indicates a compound that is able to influence the growth of a nanoparticle to assume a predefined shape. Examples of common directing agents are polymers, surfactants, ionic salts and aromatic organic molecules.
“Precursor” indicates a chemical species containing at least one of the metal elements necessary for the nucleation/growth of the ferrite nanocrystals.
“Ligand” indicates a chemical species having surfactant properties that are able to form a compound with a metal.
“Ferrite” indicates a chemical compound consisting of a mixture of iron oxides and optionally of oxides of other metals selected from Fe, Mn, Co and Zn, having a high degree of magnetic permeability.
“Thermoresponsive polymer” indicates a polymer that exhibits a drastic change in physical properties as the temperature changes.
In a first aspect, the present invention relates to a method for producing ferrite nanocrystals, comprising the following steps:
i) providing a solution comprising a fatty acid, an aliphatic amine and an alcoholic solvent;
ii) adding at least one organometallic precursor compound comprising a metal selected from Fe, Mn, Co or Zn and an aromatic organic molecule to the solution in point i) in order to obtain a reaction mixture;
iii) transferring the reaction mixture obtained in step ii) to a sealed reactor, thereby obtaining a filling percentage thereof of between 20 and 70 vol. %; and
iv) heating said sealed reactor to a temperature of between 160° C. and 240° C. for at least 3 hours.
In order to prepare the solution in step i), the components may be added under magnetic agitation and heating in order to facilitate the dissolution thereof and the attainment of a homogenous solution.
Said fatty acid is preferably a saturated or unsaturated fatty acid having an alkyl chain having between 10 and 18 carbon atoms. In a particularly preferred embodiment, said fatty acid is selected from oleic acid and decanoic acid.
Said aliphatic amine may be a primary, secondary or tertiary amine. Said aliphatic amine preferably has an alkyl chain having between 8 and 18 carbon atoms. Even more preferably, said aliphatic amine is hexadecylamine.
Said alcoholic solvent is selected from linear alcohols having an alkyl chain of between 2 and 8 carbon atoms and benzyl alcohol. In a particularly preferred embodiment, said alcohols are selected from 1-butanol and 1-octanol.
In step ii), the components may be added in the presence of magnetic agitation and at a temperature of between room temperature and the dissolution temperature used in step i).
In a particularly preferred embodiment, said organometallic precursor compound is selected from iron pentacarbonyl of formula Fe(CO)5, zinc acetylacetonate of formula Zn(AcAc)2, cobalt(II) acetylacetonate of formula Co(AcAc)2, manganese acetylacetonate of formula Mn(AcAc)2, and mixtures thereof.
Said aromatic organic material is selected from molecules having a low molecular weight able to facilitate the anisotropic growth of nanocrystals. Said molecules are preferably aldehyde molecules. Examples of suitable molecules are benzaldehyde, 4-biphenyl carbaldehyde, 2-phenylpropionaldehyde, 1,4-benzenedicarboxaldehyde, 4-methylbenzaldehyde, vinylbenzaldehyde, isopropenylbenzenaldehyde, 4-isopropylbenzaldehyde, 4-(1-methylethyl)benzaldehyde. In a particularly preferred embodiment, said aromatic organic molecule is benzaldehyde.
In the embodiments in which said organic molecule is in the solid state at room temperature and pressure, it may be added to step i) to facilitate the dissolution thereof in the reaction mixture.
Optionally, the above-mentioned aromatic organic molecule may be used in a mixture with directing agents, such as alkylamines or trioctylphosphine (TOPO).
In step iii), said sealed reactor is preferably a Teflon-lined autoclave (for operating temperatures of up to 200° C.), or p-polyphenylene (PPL) (for temperatures above 200° C.). Alternatively, any reactors on the market may be used that may be sealed and pressurized, for example Parr® reactors. The use of a sealed reactor makes it possible to obtain an autogenous pressure inside said reactor and this pressure ensures the high degree of crystallinity of the end product, despite the reduced operating temperature. Extensive studies have made it possible to determine the importance of parameters such as the reactor volume and the filling percentage thereof on the end properties of the ferrite nanocrystals, as shown in Example 6. In particular, a general trend was found in which, as the degree to which the reactor is filled increases, the reaction yield decreases and the average diameter of the nanocrystals obtained increases, while, as the volume of the reactor increases, the yield increases and the average diameter decreases. Furthermore, as the reaction temperature increases, an increase in the average dimensions of the nanocrystals obtained is observed. In any case, as each of these parameters varies, that is the volume of the reactor, the filling percentage or the temperature, the monodispersion and the cubic shape of the nanocrystals are not influenced.
Preferably, said filling percentage of the reactor is between 40 and 55 vol. %.
The process of heating the reactor in point iv) is preferably carried out by inserting said sealed reactor into a pre-heated furnace at the solvothermal reaction temperature.
The reaction temperature is preferably between 200 and 240° C.
The reactor is preferably held at the reaction temperature for between 3 and 6 hours.
In a preferred embodiment, the ferrite nanocrystals obtained according to the method of the present invention are transferred to water by means of a ligand-exchange step or a polymeric covering step.
As is known in the above-cited document WO 2013/150496, for example, in order to facilitate the transfer of nanocrystals to the required final use solvents, the nanocrystals may be functionalized with suitable ligands. Advantageously, the nanocrystals obtained according to the method described above readily lend themselves to being subjected to a variety of ligand-exchange methods or to methods of polymeric covering on the surface, obtaining transfer rates close to 100% and stable dispersions even in the long term, as illustrated in Example 8.
The ligand exchange may advantageously be carried out using tetramethylammonium hydroxide, polyethylene glycol and derivatives thereof. Examples of polyethylene glycol derivatives are gallol polyethylene glycol and α-nitrodopamine-ω-carboxypoly(ethylene glycol).
The polymeric covering may advantageously be carried out using an amphiphilic polyanhydride. Examples of amphiphilic polyanhydrides are poly(maleic anhydride-alt-1-octadecene), poly(maleic anhydride-alt-1-tetradecene), poly(maleic anhydride-polyisobutylene).
In another preferred embodiment, the ferrite nanocrystals obtained according to the method of the present invention are subjected to functionalization with a radical polymerization initiator for a monomer or comonomers susceptible to forming a thermoresponsive or pH-responsive polymer.
As described in patent application WO 2018/138677 by the same applicant, for example, this type of ferrite nanocrystal functionalization makes it possible to develop multi-functional materials that may permit the controlled release of a drug. When functionalizing with thermoresponsive polymers, the heat generated by the magnetic nanoparticles during magnetic hyperthermia treatment may be used to bring the temperature of the solution to above the lower critical solution temperature (also called the LCST), thereby causing the contraction of the polymeric chain and facilitating the release of a previously charged drug.
Therefore, proceeding from the nanocrystals obtained according to the method of the present invention, it is possible to introduce a radical initiator on the surface of the particles by means of a ligand-exchange method and to thereby obtain macroinitiator particles to be used in the subsequent photoinduced polymerization step of the comonomers of a thermoresponsive polymer. In particular, Example 9 demonstrates how cubic ferrite nanocrystals that are obtained according to the method of the present invention and covered with a thermoresponsive polymer having an LCST close to 42° C. by means of copper-mediated photoinduced free-radical polymerization make it possible to obtain a material that combines excellent heating properties with thermoresponsive characteristics in a biological environment.
The method described thus far is used in the large-scale preparation of nanocrystals for use in magnetic hyperthermia, with numerous advantages. In particular, said method makes it possible to obtain high yields of magnetic nanoparticles, while simultaneously maintaining a high level of control of the dimensions, dispersion and colloidal properties of the end product. More specifically, the method described here has obvious advantages over the thermal decomposition synthesis methods, since it does not require operating in an atmosphere devoid of oxygen and under magnetic agitation, thereby substantially reducing the times and costs of the entire production process. Furthermore, the thermal profile of the method developed here is more direct and simple; it in fact consists of just one heating step to temperatures below those used in the known thermal decomposition methods and reduced reaction times. With respect to the solvothermal synthesis methods, the method described here makes it possible to obtain cubic nanoparticles having a greater degree of crystalline purity, reduced dimensions and lower polydispersion, consequently having better magnetic and colloidal properties.
8 mL (equal to 51 mmol) of 1-octanol (anhydrous, ≥99% Sigma-Aldrich), 0.2 g (equal to 0.8 mmol) of hexadecylamine (HDA, 98%, Sigma-Aldrich) and 0.6 mL (equal to 1.9 mmol) of oleic acid (OA, ≥99% , GC, Sigma-Aldrich) were brought into a homogenous solution in a two-neck round-bottom flask (25 mL, with an opening for the insertion of a thermocouple) at 60° C. using a heating jacket (the temperature is simply monitored, but a specific ramp is not applied) for 30 minutes with magnetic agitation (1100 rpm). No condensing units are required, no specific pressure and the dissolution was carried out under atmospheric pressure. After this, the solution was left to cool down to room temperature (RT) naturally. 2 mL (equal to 14.8 mmol) of iron pentacarbonyl (Sigma-Aldrich, >99.99%, purity in terms of metal traces) were then added at room temperature with magnetic agitation (1100 rpm). After 30 minutes, 1 mL of benzaldehyde (Sigma-Aldrich, ReagentPlus®, ≥99%) was added as the directing agent. After 30 minutes, the solution was transferred to a Teflon-lined 25-mL autoclave that is filled up to 46.4 vol. % and is sealed in a stainless-steel jacket. The reactor was introduced into a furnace pre-heated to 200° C. and maintained for 6 hours, where the sample was subjected to the solvothermal crystallization process. No type of magnetic agitation was applied during the solvothermal reaction in order to prevent the possible aggregation of the nanoparticles formed, which may happen due to the magnetic characteristics of the product. The pressure inside the reactor may reach values of between 1.2 and 60 bar. For example, the pressure reached inside a Parr® reactor (Series 4560, 100 mL) was measured reaching values of between 20 and 60 bar during the reaction. At the end of the solvothermal reaction in the furnace, the reactor was left to cool down to room temperature naturally. The contents of the autoclave were then transferred to two 45-mL Falcon™ tubes with the aid of chloroform up to a volume of 15 mL. The Falcon™ tubes were subjected to ultrasound for 2 minutes, 30 mL of acetone were added, were briefly agitated and were subjected to centrifugation (4500 rpm for 20 min). After this, the supernatant was discarded and the product deposited in the Falcon™ tube was dispersed in 10 mL of chloroform in each tube for the subsequent characterization processes.
The nanocrystals obtained in this way were characterized by means of transmission electron microscopy (TEM). The results shown in
The procedure in Example 1 was reproduced in two separate experiments by substituting the directing agent with equimolar quantities of 2-phenylpropionaldehyde and 4-biphenyl carbaldehyde, respectively. In the first case, 1.31 mL of 2-phenylproprionaldehyde (equal to 9.8 mmol) (Sigma-Aldrich, 99%) were added as the directing agent, while in the case of 4-biphenyl carbaldehyde (Sigma-Aldrich, 98%), this compound being in the solid state in contrast to the preceding compounds, 1.82 g of 4-biphenyl carbaldehyde (equal to 9.8 mmol) were directly added to the initial reaction mixture, together with 1-octanol, hexadecylamine and oleic acid, and the mixture was heated to 60° C. for 30 minutes.
The results of the TEM characterization shown in
Mn, Co or Zn ferrite nanocrystals were obtained by introducing a non-stoichiometric mixture of iron pentacarbonyl, Fe(CO)5 and zinc acetylacetonate, Mn(AcAc)2, Co(AcAc)2 or Zn(AcAc)2.
The experimental procedure carried out is the same as in Example 1 for the preparation of magnetite nanocubes, with the exception of a single modification. After the dissolution of oleic acid and hexadecylamine at 60° C., the metallic precursors were added at this temperature: initially, 0.5 mmol of manganese (II), cobalt (II) or zinc (II) acetylacetonate were dissolved (under magnetic agitation at 1100 rpm for 30 minutes) and then 14.3 mmol of iron pentacarbonyl. Benzaldehyde was then added and the solution was subjected to the solvothermal reaction as described in Example 1.
The nanocrystals obtained using Zn(AcAc)2 obtained in this way were characterized by means of transmission electron microscopy (TEM) and by means of dynamic light scattering (DLS) measurements to determine the shape and dimensions thereof. The results obtained and shown in
The sample was then characterized by means of X-ray diffractometry recorded for angular values 2θ in the range of 20-80° (Cu Kα) and the diffractogram obtained and shown in
The elementary analysis was carried out by means of inductively coupled plasma atomic emission spectroscopy (ICP-AES) in order to identify the chemical composition of the sample, which turned out to be Zn0.6Fe2.4O4.
In the case of manganese ferrite nanocubes obtained using Mn(AcAc)2 as the precursor, the average diameter of the nanocubes is 12±1 nm, as observed in
By means of this study, the crucial role that the presence of the directing agent plays on the shape, polydispersion and colloidal stability of the nanoparticles obtained according to the method described here was established.
In this regard, the experimental procedure described in Example 1 was repeated without the addition of benzaldehyde as the directing agent, and the structural and colloidal properties were compared by means of TEM and DLS analyses of the nanoparticles obtained according to the two synthesis methods.
As may be seen in
In order to compare the colloidal properties, the same ligand-exchange protocol using tetramethylammonium hydroxide (TMAOH) was applied to both samples. This is a short ligand (L) that may replace the organic surfactant on the surface of the cubic nanocrystal, providing a negative charge having a physiological pH that are able to improve the stability by means of charge repulsion. By means of experimentation, the synthesized samples were collected in a glass vial by means of centrifugation (4500 rpm for 20 minutes), dried by means of an air flow and an ethanol solution containing the ligand was added. The solutions were treated with ultrasound for 30 minutes and the solvent was then exchanged for water using an Amicon® centrifugal filter (100-K MWCO). For the ligand-exchange process, 200 L/nm2 were used. Only with the sample prepared using benzaldehyde during the solvothermal process did the stability of the nanocubes in an organic phase prove to be very good, and therefore the ligand exchange was direct and worked without any complications. The stability of both the samples after the ligand exchange was evaluated by hydrodynamic dimension measurements using the DLS technique. As shown in
The products obtained by means of the solvothermal method of the present invention were compared with the nanocubes obtained by means of a solvothermal method by Sun et al. (cited above).
According to the procedure by Sun et al., 0.20 g (0.8 mmol) of hexadecylamine and 2.0 mL (6.33 mmol) of oleic acid were added to 8.0 mL of 1-octanol and the mixture was heated to approximately 50° C. under magnetic agitation to form a homogenous solution. After this, the solution was cooled down to room temperature and 2.0 mL (14.8 mmol) of Fe(CO)5 were added. The mixture continued to be agitated and was transferred to a 25-mL Teflon autoclave. The autoclave was introduced into a pre-heated furnace at 200° C. for 80 minutes. After cooling to room temperature, the precipitate was separated by means of centrifugation and dispersed in chloroform. The two methods differ significantly in the ratio between [oleic acid] [hexadecylamine], which is 2.4 in the method of the invention and 7.9 in the reference method, in the duration of the solvothermal crystallization process, which is 6 hours in the invention and 80 minutes in the reference method, and above all in the presence of benzaldehyde. At the end of the synthesis process according to the reference method, a small amount of material was retrieved as the precipitate at the bottom of the reactor and had an ochre color in contrast to the black color of the precipitate obtained according to the invention. The nanoparticles obtained according to the reference method are predominantly nanocubes having average dimensions of 26 ±2 nm in accordance with what stated by the authors and having the dimensions that are obtainable according to the present invention (21 ±2). However, as may be seen in the TEM images shown in
The magnetic performance (SAR) and heating behavior of the cubic magnetite nanocrystals obtained according to Example 1 were studied and compared by applying an AC magnetic field and recording the temperature increase verified by the different colloidal nanoparticle systems. AC magnetic fields having different frequencies (105 kHz, 220 kHz and 300 kHz) and amplitudes of up to 32 kAm−1 were applied. All measurements were carried out in water (Cwater=4185 JL−1K−1). The SAR values recorded were calculated by the average of four measurements on one sample having a volume of 0.3 mL and an iron concentration of 4-7 mg/mL in order to guarantee measurement conditions in which heat dissipation is close to adiabaticity. Only the first seconds were used to calculate the gradient of the curve and the SAR values.
The heating properties of the magnetite nanocubes according to the invention were compared with: i) the corresponding nanoparticles having an irregular shape obtained in the absence of a directing agent according to Example 4; ii) the FeO nanocubes prepared according to Example 5, and iii) nanocubes obtained by means of thermal decomposition according to the method described in the above-cited publication by Guardia et al.
As may be seen from the results shown in
The same type of comparison, shown in
Furthermore, the heating properties of the magnetite nanocubes according to the present invention were compared, following the same techniques mentioned above, with the nanocubes obtained by thermal decomposition according to what described by Guardia et al. As may be observed from the results shown in
At the end of the synthesis process, these products also appeared to be homogenously dispersed and easily transferable to other organic or aqueous means. In the case of the aqueous means, tetramethylammonium hydroxide (TMAOH) was used as the stabilizing agent following a ligand-exchange process. Following the same process, the mixed Zn and Mn ferrite nanocubes were also transferred to water and then used for the calorimetric measurements.
As may be seen from the data shown in
In these experiments, the effects of i) the volume of the reactor and the filling percentage thereof and ii) the reaction temperature on the dimensions of the end product were examined separately.
The study of the effect of the volume was carried out by repeating the experimental conditions in Example 1 in autoclaves having a volume of 50 and 100 mL by multiplying the quantity of reagent used in Example 1, in which a 25-mL reactor was used, by a factor of 2 and 4, respectively. As may be seen from the data shown in
The following table shows the mass of iron values obtained for each reactor at different temperatures.
The effect of the filling percentage of the reactor was examined since, as it is known, this factor influences the internal pressure of the reactor, which in turn influences the dimensions of the nanoparticles and the final yield thereof (here expressed in terms of mass of Fe). For this purpose, tests were carried out in which the volume of the initial liquid phase varied from 10 to 32 mL in a 50-mL autoclave, thereby obtaining a corresponding variation in the filling percentage from 20 to 70%. As shown by the results in
From the point of view of the yield, it was observed that the method described here achieves a conversion into nanoparticles yield of up to 23% by mass of iron.
Lastly, it was found that, by setting the volume of the reactor to 25 mL and the filling percentage thereof to 46.4%, as the reaction temperature varies in the range of between 160 and 240° C., it is observed that an increase in the dimensions of the nanocubes in the range of between 11 and 23 nm was obtained, as shown in
For this experiment, magnetite nanocrystals having average dimensions of 14±1 nm, tetramethylammonium hydroxide (abbreviated as TMAOH or L1 here), gallol polyethylene glycol (abbreviated as GA-PEG or L2 here) α-nitrodopamine-ω-carboxypoly(ethylene glycol) (abbreviated as ND-PEG-COOH or L3 here) and poly(maleic anhydride-alt-1-octadecene) (abbreviated as POLY or P1 here) were used.
In order to carry out the exchange using L1, 15 mL of a chloroform solution containing magnetite nanocrystals where [Fe]=1 mg/mL were added to 8.2 mL of GA-PEG solution (0.1 M in chloroform containing 0.8 mL of triethylamine) and mechanically agitated overnight in an orbital agitator at room temperature. In this step, the ligand was found to have an excess of 300 L/nm2. The mixture was then transferred to a separating funnel and the nanocrystals were transferred in a liquid phase by means of liquid-liquid extraction using water/toluene. The solution was concentrated up to 10 mL under reduced pressure conditions at 50° C., the excess ligand was removed by dialysis against 5 L of deionized water using a tube cellulose membrane with pore dimensions of 50 kDa. Lastly, the dispersion containing the nanocrystals was concentrated by means of centrifugation in a centrifugal filter (molecular threshold value of 100 kDa).
In order to test ND-PEG-COOH, 148 mg of polymeric ligand (0.098 mmol) were dissolved in 3.1 mL of chloroform to obtain a solution of 0.05 M. 0.67 mL of nanocrystals in chloroform (5 mg of Fe) were added. The final concentration was 1 mg Fe/mL and a ratio of 150 ligands/nm2 was applied. 0.97 mL of triethylamine were then added (70 equivalents compared with the millimoles of ligands). The mixture was vigorously agitated overnight at room temperature to exchange the initial hydrophobic ligands with hydrophilic ND-PEG-COOH. 40 mL of toluene were then added and the nanocrystals were transferred in an aqueous phase by means of liquid-liquid extraction, as described above. After this, the sample was concentrated by means of centrifugation using an Amicon® filter (50,000 g/mol threshold value, 1500 rpm). The sample was transferred to a dialyzer having a Spectrum Labs® membrane (threshold value 100,000 g/mol, 1700 rpm) and the mixture was dialyzed for 2 days against water to purify it and further concentrated to a final volume of 2 mL.
Lastly, the nanocrystals were transferred to an aqueous means by means of polymeric covering with POLY. For this purpose, a polymer solution in chloroform was added to a dispersion of nanocrystals covered with oleic acid at a concentration of 0.01 μM in order to obtain a ratio of 500 L/nm2. The solvent was then completely removed by means of rotary evaporation and the film of nanocrystals deposited on the walls was retrieved using a buffer solution of sodium borate (50 mM, pH 9). Lastly, the solution was concentrated in a tubular centrifuge equipped with a cellulose membrane and purified with a continuous sucrose gradient of 20-66%. All the samples were then subjected to TEM and DLS characterization, the Z potential was measured and the SAR values were calculated.
The hydrodynamic dimension measurements (weighed by intensity) shown in
The negative Z potential values measured for the different samples, shown in
Lastly, the samples subjected to ligand exchange or polymeric covering were subjected to SAR measurements, the results of which are shown in
The functionalization procedure used in this example is shown schematically in
Experimentally, magnetite nanocrystals having average dimensions of 20±2 nm, diethylene glycol methyl ether methacrylate (DEGMEMA) (Aldrich, 95%) and oligoethylene glycol methyl ter methacrylate (OEGMEMMA) (Mw=500 g mol−1, Aldrich, 99%), both purified from the inhibitors by means of a basic alumina column, were used. The solvents were purchased from Sigma Aldrich with the highest degree of purity available and were used as received. Tris[2-(dimethylamino)ethyl]amine (ME6TREN) was prepared according to the method described by Ciampolini and Nardi in “Five coordinated High Spin Complexes of Bivalent Cobalt, Nickel and copper with tris(2-dimethylaminoehyl)amine.” Inorganic chemistry 5(1) :41-44 (1966). 2-bromo-N-[2-(3,4-dihydroxy-phenyl)ethyl]-butyramide (DOPA-BiBA) was prepared according to the procedure described by Fan et al. in “Biomimetic anchor for surface-initiated polymerization from metal substrates,” Journal of the American Chemical Society 127(45):15843-15847(2005).
The radical initiator was immobilized due to the high affinity of the catechol present in DOPA-BiBA towards the iron oxide surfaces, by means of a ligand-exchange procedure using an initial ratio of 500 ligand molecules per nm2 of nanocrystal surface. In short, for cubic nanocrystals having a spike of 22.0 nm, the necessary amount of DOPA-BiBA was dissolved in 6.0 mL of methanol 4% (v/v) in chloroform inside a 20-mL flask. The required amount of cubic nanocrystals in chloroform was added to this solution and the suspension was subjected to treatment with ultrasound for 30 seconds. Triethylamine (TEA) was then added to the mixture in a stoichiometric ratio with DOPA-BiBA. The flask was covered with an aluminum sheet to prevent exposure to the light and left overnight, while being agitated. A surplus amount of hexane was then added to the mixture to induce the precipitation of the cubic nanocrystals. The precipitate was subjected to two dispersion cycles in tetrahydrofuran (THF)/precipitation in hexane to remove the unbound initiator. After this, the cubic nanocrystals were dispersed in THF to obtain an iron concentration of 4.0 gL−1. For the actual polymerization step, 0.5 mL of the solution of cubic nanocrystals functionalized with DOPA-BiBA was diluted with 1.5 mL of dimethyl sulfoxide (DMSO) in a 40-mL flask. A mixture containing 2.5 mL of DMSO, 240 μL of OEGMEMMA and 448 μL of DEGMEMA was then slowly added to this solution, which was then treated with ultrasound for 30 seconds at room temperature and purged in nitrogen for 15 minutes. After this, 0.067 mg of a catalyst stock solution containing 0.5 mL of DMSO, 0.067 mg of CuBr2 and 0.16 μL of ME6TREN were injected into the flask. In order to start the polymerization process, the flask was held in a chilled environment at 5° C. and exposed to a UV light source (four 9-W lamps, λmax≈360 nm) while it continued to be agitated by an orbital agitator. After 2.5 hours of irradiation, the polymerization process was stopped by adding 10 mL of THF and exposing the entire thing to the air. The thermoresponsive cubic nanocrystals thus obtained were precipitated in diethyl ether and washed with two dispersion cycles in THF/precipitation in diethyl ether. The thermoresponsive cubic nanocrystals were then dissolved in water before the ultracentrifugation process using a sucrose gradient to remove the free polymer. The sucrose was removed by means of centrifugation on a filter and the stable thermoresponsive cubic nanocrystals were transferred to a pure saline solution for the characterization processes.
As may be observed from the DLS measurements shown in
Lastly, as shown in
All these data therefore confirm the possibility of functionalizing the nanocrystals obtained according to the present invention with a thermoresponsive polymer and obtaining multifunctional particles for biomedical applications able to combine magnetic hyperthermia and the controlled release of drugs.
| Number | Date | Country | Kind |
|---|---|---|---|
| 102019000006469 | Apr 2019 | IT | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/IB2020/054028 | 4/29/2020 | WO | 00 |
